| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunitybio, Inc. (IBRX) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. IBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.82M | $215.30M | - | |
| CEO | 625.5K | $4.52M | - | |
| CFO | 280.2K | $2.02M | - | |
| Other | 115.7K | $835.6K | - | |
| Dir | 65.6K | $473.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2015 | Soon-Shiong Patrick | Chairman And CEO | Buy | 450,000 | $23.00 | $10,350,000.00 | +1.1% |